BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.94
+0.18 (2.05%)
At close: Apr 24, 2026, 4:00 PM EDT
8.70
-0.24 (-2.68%)
After-hours: Apr 24, 2026, 7:51 PM EDT
BioCryst Pharmaceuticals Employees
BioCryst Pharmaceuticals had 435 employees as of December 31, 2025. The number of employees decreased by 145 or -25.00% compared to the previous year.
Employees
435
Change (1Y)
-145
Growth (1Y)
-25.00%
Revenue / Employee
$2,011,120
Profits / Employee
$606,577
Market Cap
2.24B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 435 | -145 | -25.00% |
| Dec 31, 2024 | 580 | 44 | 8.21% |
| Dec 31, 2023 | 536 | 5 | 0.94% |
| Dec 31, 2022 | 531 | 173 | 48.32% |
| Dec 31, 2021 | 358 | 112 | 45.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Phibro Animal Health | 2,475 |
| HUTCHMED (China) | 1,796 |
| ANI Pharmaceuticals | 970 |
| Supernus Pharmaceuticals | 778 |
| Prestige Consumer Healthcare | 600 |
| Harrow | 373 |
BCRX News
- 11 days ago - BioCryst to Report First Quarter 2026 Financial Results on May 6 - GlobeNewsWire
- 20 days ago - BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer - GlobeNewsWire
- 23 days ago - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - BioCryst Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - BioCryst Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - BioCryst to Present at Upcoming Investor Conference - GlobeNewsWire
- 2 months ago - BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting - GlobeNewsWire